Back to Journals » Therapeutics and Clinical Risk Management » Volume 1 » Issue 2

A review of studies of adherence with antihypertensive drugs using prescription databases

Authors Nicola Fitz-Simon, Kathleen Bennett, John Feely

Published 15 July 2005 Volume 2005:1(2) Pages 93—106

Nicola Fitz-Simon, Kathleen Bennett, John Feely

Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital, Dublin, Ireland

Abstract: Poor adherence with antihypertensive therapies is a major factor in the low rates of blood pressure control among people with hypertension. Patient adherence is influenced by a large number of interacting factors but their exact impact is not well understood, partly because it is difficult to measure adherence. Longitudinal prescription data can be used as a measure of drug supply and are particularly useful to identify interruptions and changes of treatment. Obtaining a medicine does not ensure its use; however, it has been established that continuous collection of prescription medications is a useful marker of adherence. We found 20 studies published in the last 10 years that used large prescription databases to investigate adherence with antihypertensive therapies. These were assessed in terms of patient selection, the definition of the adherence outcome(s), and statistical modeling. There was large variation between studies, limiting their comparability. Particular methodological problems included: the failure to identify an inception cohort, which ensures baseline comparability, in four studies; the exclusion of patients who could not be followed up, which results in a selection bias, in 17 studies; failure to validate outcome definitions; and failure to model the discrete-time structure of the data in all the studies we examined. Although the data give repeated measurements on patients, none of the studies attempted to model patient-level variability. Studies of such observational data have inherent limitations, but their potential has not been fully realized in the modeling of adherence with antihypertensive drugs. Many of the studies we reviewed found high rates of nonadherence to antihypertensive therapies despite differences in populations and methods used. Adherence rates from one database ranged from 34% to 78% at 1 year. Some studies found women had better adherence than men, while others found the reverse. Novel approaches to analyzing data from such databases are required to use the information available appropriately and avoid the problems of bias.

Keywords: patient adherence, antihypertensives, prescription databases

Download Article [PDF] 

Readers of this article also read:

The impact of hearing loss on the quality of life of elderly adults

Ciorba A, Bianchini C, Pelucchi S, Pastore A

Clinical Interventions in Aging 2012, 7:159-163

Published Date: 15 June 2012

Surface activity of surfactant spiked with vitamin A

Vadim Bronshtein, Vugranam Venkatesh, Jas Aulakh, Philippe Chessex

Drug Design, Development and Therapy 2008, 2:145-150

Published Date: 14 August 2008

Management of oxaliplatin-induced peripheral neuropathy

M Wasif Saif, John Reardon

Therapeutics and Clinical Risk Management 2005, 1:249-258

Published Date: 15 December 2005

Lifestyle changes as a treatment of gastroesophageal reflux disease: a survey of general practitioners in North Queensland, Australia

Madeleine Nowak, Petra Büttner, Beverly Raasch, Kym Daniell, Cindy McCutchan, Simone Harrison

Therapeutics and Clinical Risk Management 2005, 1:219-224

Published Date: 15 October 2005

Absence of the toll-like receptor 4 gene polymorphisms Asp299Gly and Thr399Ile in Singaporean Chinese

Xiao Hui Liang, Wai Cheung, Chew Kiat Heng, De-Yun Wang

Therapeutics and Clinical Risk Management 2005, 1:243-246

Published Date: 15 October 2005

Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy

Charity D Scripture, William D Figg, Alex Sparreboom

Therapeutics and Clinical Risk Management 2005, 1:107-114

Published Date: 15 July 2005

The controversy surrounding OxyContin abuse: issues and solutions

Sujata S Jayawant, Rajesh Balkrishnan

Therapeutics and Clinical Risk Management 2005, 1:77-82

Published Date: 15 July 2005